Alyssum Therapeutics Inc Press Releases - EIN Presswire - Press Release Distribution Service

Published on February 6, 2025 - 13:00 GMT

Alyssum Therapeutics Expands Leadership Team With Track-Record of Multiple Accelerated Approvals

CAMBRIDGE, MA, NJ, UNITED STATES, February 6, 2025 /⁨EINPresswire.com⁩/ -- Alyssum Therapeutics, a clinical stage immunology company, expands stellar leadership team with track-record of multiple accelerated approvals Alyssum Therapeutics, on the heels …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2025 - 14:00 GMT

Alyssum Therapeutics, a clinical stage immunology company, expands Series A with participation from Femhealth Ventures

• Will fund clinical trials with a first in class, clinical stage CMTR2 inhibitor that activates a B cell immune response against tumors CAMBRIDGE, MA, UNITED STATES, January 8, 2025 /⁨EINPresswire.com⁩/ -- Alyssum Therapeutics, which recently came out of …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on October 23, 2024 - 16:00 GMT

Alyssum Therapeutics closes Series A and emerges from stealth mode as a clinical stage B cell immunology company

• A clinical stage B cell immunotherapy company for cancer and autoimmune diseases • Alyssum team has collectively developed over twenty clinical therapeutics CAMBRIDGE, MA, UNITED STATES, October 23, 2024 /⁨EINPresswire.com⁩/ -- Alyssum Therapeutics, …

Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...